About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Chicago | 715 Studies

Clinical Trials Breast CancerChicago

Breast Cancer Clinical Trials in Chicago

Find 715 clinical trials for breast cancer near Chicago, Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 715 trials

CompletedPhase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast CancerThis phase II trial studies how well everolimus with or without trastuzumab works in treating patients with breast cancer that has not responded to hormone therapy and has spread…NCT00912340·Atlanta, Georgia and 3 others RecruitingPRE-ISPY Phase I/II Oncology Platform ProgramPRE-ISPY Phase I/II (I-SPY-P1) is an open-label, multisite platform study with multiple ongoing drug regimen arms added by protocol amendment which is designed to evaluate single…NCT05868226·Birmingham, Alabama and 9 others

Breast Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerThe objective of this study is to compare the progression-free survival (PFS) of the drug combination ramucirumab plus docetaxel to placebo plus docetaxel in previously untreated…NCT00703326·Birmingham, Alabama and 231 others

CompletedLymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast CancerRATIONALE: Surgery to remove lymph nodes in the armpit may remove cancer cells that have spread from tumors in the breast.NCT00003855·Birmingham, Alabama and 155 others

RecruitingBRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast CancerAdult men and women with early-stage, IHC/FISH-defined HER2-positive breast cancer will have a MammaPrint®/BluePrint® assay performed on the diagnostic biopsy specimen, ordered by…NCT06441890·Chicago, Illinois

RecruitingStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesThis study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer…NCT05417594·La Jolla, California and 31 others

UnknownLetrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00382070·Anniston, Alabama and 805 others

CompletedEvaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationThis is an open label, randomized, multicenter study evaluating the activity of lasofoxifene relative to fulvestrant for the treatment of pre- and postmenopausal women with…NCT03781063·Phoenix, Arizona and 50 others

Active not recruitingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVThis phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that may have spread from where it first started to nearby tissue…NCT04514484·Chicago, Illinois and 2 others

RecruitingA Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerThis study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a…NCT06790693·Goodyear, Arizona and 240 others

CompletedTesting Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves SurvivalThis randomized phase II/III trial studies how well standard of care therapy with stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy alone…NCT02364557·Birmingham, Alabama and 161 others

TerminatedIpilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast CancerThe purpose of this research study is to look at the efficacy (the effect on tumor) and the safety (the effect on body) of the study drugs when given as a combination in patients…NCT02892734·Chicago, Illinois

CompletedMulticenter Hologic Tomosynthesis StudyThe purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective…NCT00971087·Scottsdale, Arizona and 21 others

CompletedTrial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing CancersThis is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with selected chemotherapy agents in…NCT02892123·Birmingham, Alabama and 16 others

CompletedEffect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer ScreeningRATIONALE: Lifestyle factors, such as physical activity, diet, and obesity, and hormone function may affect breast density.NCT00131950·Chicago, Illinois

Active not recruitingThe AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerThis research study is studying a combination of drugs as a possible treatment for breast cancer.NCT03414658·Birmingham, Alabama and 16 others

CompletedS0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00075764·Anniston, Alabama and 425 others

CompletedRadiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving SurgeryRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells.NCT01082211·Peoria, Arizona and 57 others

CompletedPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous (IV) administration of XmAb808 in combination with pembrolizumab in subjects…NCT05585034·Los Angeles, California and 11 others

WithdrawnSGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast CancerThis phase I trial studies the effect of SGT-53, carboplatin, and pembrolizumab in treating patients with triple negative inflammatory breast that has spread to other parts of the…NCT05093387·Chicago, Illinois

PreviousPage 11 of 36Next

Other Conditions in Chicago

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma